|
LOGIN/Member Profile |
THE APPIA MISSION Cooperative industry partners dedicated to advancing anatomic pathology to benefit patient care by advocating and fostering quality, education, and best practices. |
|
|
APPIA News Release — June 6, 2025
APPIA Announces New Officers and Directors
David Ferber elected president of the Anatomical Pathology Patient Association
The Anatomical Pathology Patient Association is pleased to announce the election of a slate of officers and directors for 2025-2026.
David Ferber, MD was elected to a two-year term as President, stepping into the seat previously held by Shalini Singh, MD, who continues to serve on the APPIA Board of Directors as Immediate Past President.
Ferber is a pathologist and Senior Medical and Scientific Affairs liaison at Leica Biosystems. He has more than 20 years of experience in anatomic and clinical practice with special interest/expertise in genitourinary pathology.
Singh is Head of Pathology at Roche Diagnostic Solutions.
Joshua Greenlee, MBA, IASSC CBB™, HT/HTL(ASCP)cm, was voted in as President-Elect. He is a Senior Product Manager & Laboratory Workflow/Productivity Strategist for Sakura Finetek USA, Inc.
Erico von Buren, MD, PhD, MOR, the Senior Director of Marketing and Strategy for Sakura Finetek USA, Inc. serves as APPIA’s Treasurer.
Also serving on the Board are Fangru Lian, MD, a pathologist and Senior Medical Director at Leica Biosystems and Dionne Roberge, PMP, HT (ASCP) cm, project leader for BenchMark on market support and product improvement at Roche Diagnostic Solutions.
APPIA’s officers and directors represent corporations serving as benefactor members.
About APPIA:
APPIA is a not-for-profit membership organization dedicated to the issues affecting laboratory practices, quality, and ultimately the safety of patients. Its mission is to ensure accuracy and reduce variation in test results, proper validation studies are needed at the onset of clinical test implementation. The association advances its mission through development of various educational programs and materials on topics including TOPS, MTB and H&E Staining.
Benefactor Members:
APPIA’s Benefactor Members are manufacturing corporations that are global leaders in anatomic pathology that make meaningful contributions to the high-level focus areas of patient safety, quality assurance and standardization in the field of anatomical pathology. Upon joining APPIA Benefactors receive two APPIA Board positions.
|
APPIA News Release — November 1, 2024 New APPIA Book on H&E Staining is on the Shelf on Amazon Book includes extensive section on artifacts featuring striking illustrations The Anatomical Pathology Patient Interest Association (APPIA) is pleased to introduce Hematoxylin and Eosin Staining in Histopathology: A Comprehensive Review, a new book by Robert Lott, HTL(ASCP) that aims to provide a comprehensive overview of the principles, applications, advantages, and limitations of H&E staining in the context of tissue Pathology. The 35-page book includes “Appendices of Excellent H&E Staining and Common Artifacts with Causes and Solutions.” The book, now available on Amazon for $2.99, was published in October 2024 by APPIA and features the following co-writers who also serve on the association’s board of directors: Shalini Singh, MD; David Ferber, MD; Erico von Bueren, MD, PhD, MOR; Joshua Greenlee, MBA, IASSC CBB™, HT/HTL(ASCP)cm; Fangru Lian, MD. Notable in the book are full-color, high-resolution illustrations showing quality H&E staining with detailed descriptions of the characteristics that make them “excellent.” This book is the latest addition to APPIA’s educational portfolio which includes the Tissue Optimization and Pre-analytic Standardization (TOPS) program and Multi-Tissue Control Blocks (MTB) presentation ….Read more |
APPIA News Release — November 2, 2021
APPIA and NSH Partner to Offer CEU Around TOPS Program
The Anatomical Pathology Patient Interest Association (APPIA) and the National Society for Histotechnology (NSH) are pleased to announce an educational partnership for APPIA’s Tissue Optimization and Pre-analytic Standardization (TOPS) Program.
Under the terms of the partnership, NSH will utilize their e-learning Management System to issue continuing education credits (CEUs) for the TOPS Program, allowing histology and medical laboratory professionals to maintain their certification and licensure requirements. NSH will provide 1 continuing education credit to registrants that complete the online course.
Find the course description and registration link on the NSH e-learning site….Read more
NSH 2021
September 15, 2021 2:30pm – 2:45pm (EST)
Robert Lott, HTL(ASCP) will be hosting an APPIA-sponsored Express Talk about TOPS.
Mr. Lott is a frequent speaker and educator at both national and regional National Society for Histotechnology meetings and one of the collaborative authors of the complete APPIA TOPS Program. He has narrated the TOPS Program for Laboratory Personnel (Histotechnologists and Medical Technologists) – Available Here.
APPIA News Release — July 12, 2021
APPIA Announces 2021-2023 Officers and Directors
The Anatomical Pathology Patient Association is pleased to announce the election of a slate of officers and directors for 2021-2023.
Erico von Bueren was elected to a two-year term as President, stepping into the seat previously held by Beth Sheppard, who continues to serve on the APPIA Board of Directors as Immediate Past President.
Mr. von Bueren is Director of Marketing for Sakura Finetek USA, Inc….Read more
APPIA News Release — June 23, 2021
APPIA Article in AIMM Journal Recommends Solutions for Low-Incidence Validation of Rare Tissues and Antigens
A new article published in the Applied Immunohistochemistry & Molecular Morphology Journal outlines recommendations from the Anatomical Pathology Patient Interest Association (APPIA) for practical solutions available to anatomic pathology laboratories for validation of immunohistochemistry (IHC) staining for low-incidence, rare tissues and antigens with low frequency of occurrence.
These recommendations are in response to the comprehensive guidelines…Read more
Read AIMM Article